Nabi Biopharmaceuticals (NABI) Announces Withdrawal of Biotest's Indemnification Claim
Tweet Send to a Friend
Nabi Biopharmaceuticals (Nasdaq: NABI) announced that Biotest Pharmaceuticals Corporation has withdrawn and released a claim representing $50.4 million of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
